You are here: Home 
Features Medicine/Drugs
What if we could forecast which people would suffer from Type 1 diabetes years before it happened?
Why focus on a disease for which there is no cure, when there are no resources available to treat it? For many people in poor countries, Banting and Best’s innovation, and development of life-saving insulin, might as well not exist.
Bariatric surgery early in the course of a patient’s diabetes is far more likely to produce remission, and sustained improvements in blood pressure and cholesterol levels, than the same procedure performed as a “last resort.”
Our digestive system is marvelously effective at breaking food down into its molecular components. Getting a group of active insulin molecules through this mill and releasing insulin at just the right time and place is a breakthrough accomplishment.
The tiny eggs of pig whipworms may be key in slowing down Type 1 diabetes, and preventing it altogether in children at risk of the disease.
Even if your 90-day or six-month A1c level is at or below 7, hold the applause. A great A1c is only one part of the diabetes control equation. How you get there matters just as much as the number itself. Just like a bank account whose average balance is $1000, but which gets there by fluctuating between zero and $2000, your long-term average glucose level can result from a number of highs and lows well out of your target range…
AFREZZA is a technology-cum-therapy that delivers bolus insulin for mealtime glycemic control. It combines a small inhaler with an aspirin-size caplet of insulin bonded to a fine, powdery substance that, when inhaled, makes man-made recombinant insulin act very much like the naturally produced counterpart
“We’re exploring using materials that release, slowly, low amounts of drugs at the implant site for many years. Instead of a future with daily pills or injections, it’s feasible to have patients come in every three, five or seven years and have the BioHub refilled or replaced.”
You’ve read the story; now, watch the movie. Meet the people and explore the science behind BioHub, the Diabetes Research Institute’s new “mini-organ,” a possible implantable cure for Type 1 diabetes.
“The BioHub is a localized micro-environment,” said Ricordi. “It is a quantum leap in cell therapy to replace insulin-producing cells that are destroyed by diabetes.” Is this the breakthrough we’ve been waiting for?
New Cleveland Clinic study shows two-year diabetes remission and normal pancreatic function in many Type 2 patients who underwent gastric bypass surgery.
“It’s a lot like shrink wrapping,” said Dr. Alice Tomei of the islet cell encapsulation technique she uses. This “conformal coating” technology is just one way researchers at Miami’s Diabetes Research Institute protect transplanted islet cells.
Bariatric Surgeries Can Cure Type 2 Diabetes. But They’re No Free Lunch.
Type 2 for twenty years +, Renee learned that going on insulin wasn’t because she was a “bad diabetic.” Within three months,. she was under control.
“Connected Care” Puts Expert Advice In The Palm of Your Hand
The Diabetes Research Institute’s “oxygen sandwich” may help Chris Fraker and his coworkers make islet cell transplantation — and a cure — more accessible to Type 1s.
